Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Prestige Consumer Healthcare (PBH) Long-Term Debt Issuances (2020 - 2021)

Prestige Consumer Healthcare has reported Long-Term Debt Issuances over the past 7 years, most recently at $600.0 million for Q1 2021.

For Q1 2021, Long-Term Debt Issuances rose 250.0% year-over-year to $600.0 million; the TTM value through Dec 2022 reached $600.0 million, up 200.0%, while the annual FY2022 figure was $597.0 million, 0.5% down from the prior year.
Long-Term Debt Issuances for Q1 2021 was $600.0 million at Prestige Consumer Healthcare, up from -$400.0 million in the prior quarter.
Over five years, Long-Term Debt Issuances peaked at $600.0 million in Q1 2021 and troughed at -$400.0 million in Q1 2020.